CorMedix (CRMD) Non-Current Deffered Revenue (2010 - 2015)
CorMedix (CRMD) reported Non-Current Deffered Revenue of $28878.0 for Q4 2015, up 163.65% sequentially from $10953.0 in Q1 2013.
CorMedix (CRMD) Non-Current Deffered Revenue (2010 - 2015) Analysis & Trends
CorMedix (CRMD) has 5 years of Non-Current Deffered Revenue data on file, last reported at $28878.0 in Q4 2015.
- For the quarter ending Q4 2015, Non-Current Deffered Revenue changed N/A year-over-year to $28878.0; the trailing twelve-month figure through Dec 2015 stood at $28878.0 (changed N/A YoY), and the FY2015 full-year result was $28878.0, changed N/A from the prior year.
- Non-Current Deffered Revenue rose to $28878.0 in Q4 2015, from $10953.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $28878.0 in Q4 2015 to a low of $10953.0 in Q1 2013.
- A 4-year average of $15236.9 and a median of $13900.0 in 2012 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue decreased 13.65% in 2011 and retreated 21.2% in 2013, its largest moves.
- Tracing CRMD's Non-Current Deffered Revenue over 4 years: stood at $14472.0 in 2011, then retreated by 15.8% to $12185.0 in 2012, then fell by 10.11% to $10953.0 in 2013, then surged by 163.65% to $28878.0 in 2015.
- Business Quant data shows CRMD's Non-Current Deffered Revenue at $28878.0 in Q4 2015, $10953.0 in Q1 2013, and $12185.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 28,878.00 |
| Mar 31, 2013 | 10,953.00 |
| Dec 31, 2012 | 12,185.00 |
| Sep 30, 2012 | 12,756.00 |
| Jun 30, 2012 | 13,328.00 |
| Mar 31, 2012 | 13,900.00 |
| Dec 31, 2011 | 14,472.00 |
| Sep 30, 2011 | 15,044.00 |
| Jun 30, 2011 | 15,616.00 |
| Dec 31, 2010 | 16,759.00 |